Medicare Benefits Schedule - Item 71175

A test, requested by a specialist or consultant physician, to diagnose neuromyelitis optica spectrum disorder (NMOSD) or myelin oligodendrocyte glycoprotein antibody‑related demyelination (MARD), by the detection of one or more antibodies, for a patient:

1. suspected of having NMOSD or MARD; and
2. with any of the following:
   1. recurrent, bilateral or severe optic neuritis;
   2. recurrent longitudinal extensive transverse myelitis (LETM);
   3. area postrema syndrome (unexplained hiccups, nausea or vomiting);
   4. acute brainstem syndrome;
   5. symptomatic narcolepsy or acute diencephalic clinical syndrome with typical NMOSD magnetic resonance imaging lesions;
   6. symptomatic cerebral syndrome with typical NMOSD magnetic resonance imaging lesions;
   7. monophasic neuromyelitis optica (no recurrence, and simultaneous or closely related optic neuritis and LETM within 30 days of each other);
   8. acute disseminated encephalomyelitis;
   9. aseptic meningitis and encephalomyelitis;
   10. poor recovery from multiple sclerosis relapses

Applicable not more than 4 times in 12 months

Fee: $50.00 Benefit: 75% = $37.50 85% = $42.50

• Previous - Item 71170
• Next - Item 71180